Predictors of patient preference for either whole body magnetic resonance imaging (WB-MRI) or CT/ PET-CT for staging colorectal or lung cancer.


Journal

Journal of medical imaging and radiation oncology
ISSN: 1754-9485
Titre abrégé: J Med Imaging Radiat Oncol
Pays: Australia
ID NLM: 101469340

Informations de publication

Date de publication:
Aug 2020
Historique:
received: 13 02 2020
accepted: 27 03 2020
pubmed: 16 5 2020
medline: 3 7 2021
entrez: 16 5 2020
Statut: ppublish

Résumé

Whole body magnetic resonance imaging (WB-MRI) may be more efficient in staging cancers, but can be harder for patients to tolerate. We examined predictors of patient preference for WB-MRI vs. CT/ PET-CT for staging colorectal or lung cancer. Patients recruited prospectively to two multicentre trials comparing diagnostic accuracy of WB-MRI with standard staging scans were sent two questionnaires: the first, administered at trial registration, captured demographics, educational level and comorbidities; the second, administered after staging completion, measured emotional distress (GHQ-12), positive mood (PANAS), perceived scan burden, patients' beliefs about WB-MRI, and preference for either WB-MRI or CT (colorectal trial), WB-MRI or PET-CT (lung trial). Preference for WB-MRI or CT/ PET-CT was analysed using logistic regression. Baseline and post-staging questionnaires were completed by 97 and 107 patients, respectively. Overall, 56/107 (52%) preferred WB-MRI over standard scans and were more likely to have no additional comorbidities, higher positive mood, greater awareness of potential benefits of WB-MRI and lower levels of perceived WB-MRI scan burden. In adjusted analyses, only awareness of potential WB-MRI benefits remained a significant predictor (OR: 1.516, 95% CIs 1.006-2.284, P = 0.047). Knowledge that WB-MRI does not use radiation predicted preference (adjusted OR: 3.018, 95% CIs 1.099-8.288, P = 0.032), although only 45/107 (42%) patients were aware of this attribute. A small majority of patients undergoing staging of colorectal or lung cancer prefer WB-MRI to CT/ PET-CT. Raising awareness of the potential benefits of WB-MRI, notably lack of ionizing radiation, could influence preference.

Identifiants

pubmed: 32410378
doi: 10.1111/1754-9485.13038
pmc: PMC8425331
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

537-545

Subventions

Organisme : University College London
Organisme : UCLH Charitable Foundation
Organisme : Health Research
Organisme : Health Technology Assessment Programme
ID : 10/68/01
Organisme : Department of Health
ID : 10/68/01
Pays : United Kingdom
Organisme : Roy Castle Lung Cancer Foundation
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Rosetrees Trust
Organisme : Department of Health
ID : ICA-CDRF-2017-03-053
Pays : United Kingdom

Investigateurs

A Aboagye (A)
L Agoramoorthy (L)
S Ahmed (S)
A Amadi (A)
G Anand (G)
G Atkin (G)
A Austria (A)
S Ball (S)
F Bazari (F)
R Beable (R)
H Beedham (H)
T Beeston (T)
N Bharwani (N)
G Bhatnagar (G)
A Bhowmik (A)
L Blakeway (L)
D Blunt (D)
P Boavida (P)
D Boisfer (D)
D Breen (D)
S Burke (S)
R Butawan (R)
Y Campbell (Y)
E Chang (E)
D Chao (D)
S Chukundah (S)
B Collins (B)
C Collins (C)
V Conteh (V)
J Couture (J)
J Crosbie (J)
H Curtis (H)
A Daniel (A)
L Davis (L)
K Desai (K)
M Duggan (M)
S Ellis (S)
C Elton (C)
A Engledow (A)
C Everitt (C)
S Ferdous (S)
A Frow (A)
M Furneaux (M)
N Gibbons (N)
R Glynne-Jones (R)
A Gogbashian (A)
S Gourtsoyianni (S)
A Green (A)
Laura Green (L)
Liz Green (L)
A Groves (A)
A Guthrie (A)
E Hadley (E)
A Hameeduddin (A)
G Hanid (G)
S Hans (S)
B Hans (B)
A Higginson (A)
L Honeyfield (L)
H Hughes (H)
J Hughes (J)
L Hurl (L)
E Isaac (E)
M Jackson (M)
A Jalloh (A)
R Jannapureddy (R)
A Jayme (A)
A Johnson (A)
E Johnson (E)
P Julka (P)
J Kalasthry (J)
E Karapanagiotou (E)
S Karp (S)
C Kay (C)
J Kellaway (J)
S Khan (S)
D Koh (D)
T Light (T)
P Limbu (P)
S Lock (S)
I Locke (I)
T Loke (T)
A Lowe (A)
N Lucas (N)
S Maheswaran (S)
S Mallett (S)
E Marwood (E)
J McGowan (J)
F Mckirdy (F)
T Mills-Baldock (T)
T Moon (T)
V Morgan (V)
S Nasseri (S)
P Nichols (P)
C Norman (C)
E Ntala (E)
A Nunes (A)
A Obichere (A)
J O'Donohue (J)
I Olaleye (I)
A Onajobi (A)
T O'Shaughnessy (T)
A Padhani (A)
H Pardoe (H)
W Partridge (W)
U Patel (U)
K Perry (K)
W Piga (W)
D Prezzi (D)
K Prior (K)
S Punwani (S)
J Pyers (J)
H Rafiee (H)
F Rahman (F)
I Rajanpandian (I)
S Ramesh (S)
S Raouf (S)
K Reczko (K)
A Reinhardt (A)
D Robinson (D)
P Russell (P)
K Sargus (K)
E Scurr (E)
K Shahabuddin (K)
A Sharp (A)
B Shepherd (B)
K Shiu (K)
H Sidhu (H)
I Simcock (I)
C Simeon (C)
A Smith (A)
D Smith (D)
D Snell (D)
J Spence (J)
R Srirajaskanthan (R)
V Stachini (V)
S Stegner (S)
J Stirling (J)
N Strickland (N)
K Tarver (K)
J Teague (J)
M Thaha (M)
M Train (M)
S Tulmuntaha (S)
N Tunariu (N)
K van Ree (K)
A Verjee (A)
C Wanstall (C)
S Weir (S)
S Wijeyekoon (S)
J Wilson (J)
S Wilson (S)
T Win (T)
L Woodrow (L)
D Yu (D)

Informations de copyright

© 2020 The Authors. Journal of Medical Imaging and Radiation Oncology published by John Wiley & Sons Australia, Ltd on behalf of Royal Australian and New Zealand College of Radiologists.

Références

Br J Clin Psychol. 2004 Sep;43(Pt 3):245-65
pubmed: 15333231
Radiology. 2015 May;275(2):545-52
pubmed: 25803490
J Pers Soc Psychol. 1988 Jun;54(6):1063-70
pubmed: 3397865
BMC Cancer. 2017 May 2;17(1):299
pubmed: 28464835
Patient. 2016 Dec;9(6):525-536
pubmed: 27167075
Psychol Med. 1997 Jan;27(1):191-7
pubmed: 9122299
J Magn Reson Imaging. 2015 Aug;42(2):247-60
pubmed: 25365936
Radiology. 2004 May;231(2):393-8
pubmed: 15031431
Lancet Respir Med. 2019 Jun;7(6):523-532
pubmed: 31080129
Injury. 2014 Sep;45(9):1345-9
pubmed: 24742979
Endoscopy. 1994 May;26(4):342-6
pubmed: 8076565
Radiat Res. 2000 Aug;154(2):178-86
pubmed: 10931690
Lancet Gastroenterol Hepatol. 2019 Jul;4(7):529-537
pubmed: 31080095
Eur Radiol. 2019 Jul;29(7):3889-3900
pubmed: 30937589
Br J Radiol. 2018 Jun;91(1086):20170731
pubmed: 29528257
Eur Radiol. 2011 Oct;21(10):2046-55
pubmed: 21626363
Br J Cancer. 2001 Apr 20;84(8):1011-5
pubmed: 11308246
J Med Imaging Radiat Oncol. 2015 Jun;59(3):300-5
pubmed: 25900704
Br J Radiol. 2012 May;85(1013):523-38
pubmed: 21343316
JAMA. 1993 Aug 11;270(6):745-7
pubmed: 8336378
BMC Res Notes. 2014 Dec 16;7:922
pubmed: 25515327
BMJ Open. 2017 Sep 6;7(9):e016391
pubmed: 28882915
Psychooncology. 2015 Apr;24(4):433-41
pubmed: 25201175
Int J Qual Health Care. 2015 Oct;27(5):384-95
pubmed: 26265160
Eur J Radiol. 2014 Jan;83(1):163-6
pubmed: 24211036
Br J Radiol. 2015 Aug;88(1052):20150121
pubmed: 26090825

Auteurs

Anne Miles (A)

Department of Psychological Sciences, Birkbeck, University of London, London, UK.

Ruth Ec Evans (RE)

Department of Psychological Sciences, Birkbeck, University of London, London, UK.

Steve Halligan (S)

Centre for Medical Imaging, University College London, Charles Bell House, UK.

Sandy Beare (S)

Cancer Research UK, University College London Clinical Trials Centre, London, UK.

John Bridgewater (J)

UCL Cancer Institute, Paul O Gorman Building, London, UK.

Vicky Goh (V)

Cancer Imaging, School of Biomedical Engineering and Imaging Sciences, King's College London, Strand, London, UK.

Sam M Janes (SM)

Lungs for Living Research Centre, UCL Respiratory, Division of Medicine, University College London, London, UK.

Neal Navani (N)

Department of Thoracic Medicine, UCLH and Lungs for Living Research Centre, UCL Respiratory, University College London, London, UK.

Alfred Oliver (A)

Cancer patient representatives, c/o National Cancer Research Institute, London, UK.

Alison Morton (A)

Cancer patient representatives, c/o National Cancer Research Institute, London, UK.

Steve Morris (S)

Research Department of Applied Health Research, University College London, London, UK.

Andrea Rockall (A)

Department of Surgery and Cancer, Imperial College London, Kensington, London, UK.

Stuart A Taylor (SA)

Centre for Medical Imaging, University College London, Charles Bell House, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH